Honest errors account for only about a third of errors in scientific papers, according to Adam Marcus, co-founder of the website Retraction Watch.

Cancer patients treated at oncology practices that use more systemic therapy for very advanced cancer do not have superior survival, data suggest.

Douching and using talc in the genital region are both associated with an increased risk of ovarian cancer, a new study suggests.

Accusations of data forgery and the resulting retractions of studies may erode public trust in cancer research, an expert says.

In studies addressing sources of bias and confounding, there was no evidence that cancer trial participation confers a survival benefit.

Oral targeted cancer drugs with a low net health benefit are less frequently prescribed than drugs with a medium or high net health benefit.

The US incidence of bone cancers has not increased in recent years, but the rate of death from bone cancers is on the rise, data suggest.

Experts point to a clear incentivization of quantity, rather than quality, of research output — both with the publishing ...

Most cancer drugs that have immature overall survival (OS) data when approved by the FDA do not demonstrate a significant improvement in OS after approval, data suggest.

One of President Joe Biden’s latest reelection strategies is to remind voters that former President Donald Trump tried to repeal the Affordable Care Act.

Some experts have said greater oversight of laboratory-developed tests will have negative impacts on cancer research and care ...

In April, the US Food and Drug Administration announced pipeline updates for several drugs intended to treat cancers.